<DOC>
	<DOCNO>NCT02802566</DOCNO>
	<brief_summary>The purpose study devise pilot BMI-based prenatal vitamin obese pregnant woman . Currently , pregnant woman , regardless body mass index , take prenatal vitamin . The investigator find obese pregnant woman high level inflammation oxidative stress , concomitant depletion specific antioxidant micronutrient . The investigator also find , animal model , decrease inflammation oxidative stress obese pregnancy associate improved offspring outcome . Here investigator aim understand whether BMI-based prenatal vitamin effective decreasing marker inflammation oxidative stress pregnancy complicate obesity .</brief_summary>
	<brief_title>BMI-based Vitamins Obese Pregnant Women</brief_title>
	<detailed_description>The investigator ' central hypothesis pregnancy obese woman create oxidant/anti-oxidant imbalance , adversely impact maternal health neonatal outcome . The investigator hypothesize restore oxidant/anti-oxidant balance body mass index ( BMI ) base prenatal micronutrient supplement decrease oxidative stress . The investigator aim devise prenatal vitamin supplement base maternal BMI increase serum level antioxidant vitamins obese pregnancy , assess BMI-based prenatal vitamin supplementation impact marker oxidative stress inflammation obese pregnant woman evaluate effectiveness vitamin formulation reduce oxidative stress inflammation improve growth trajectory infant bear obese woman . The investigator conduct double-blind randomized-controlled study . Two group woman randomize independently . 1 ) Obese woman ( BMI &gt; 30 ) planning pregnancy advertising mailing ( N=50 ) 2 ) Pregnant woman early pregnancy ( &lt; 13 week ) approach first prenatal visit BWH BIDMC obstetric practice ( N=120 ) . Women prescreened approached study staff qualify . After informed consent obtain , patient randomize either control intervention group computer-generated permute block randomization . All subject give standard prenatal vitamin provide study addition , control group give placebo Intervention group give supplement vitamin C , E , B6 folate . The primary outcome maternal systemic marker inflammation oxidative stress . At time point mention , follow laboratory assay conduct maternal blood urine : C reactive protein , vitamins C , E , B6 , folate 8-iso-PGF2a 8-OHdG . The secondary outcome cord blood marker inflammation oxidative stress , breastfeed success , follow infant outcome first year : neurodevelopmental outcome , growth trajectory adiposity , systemic marker inflammation oxidative stress .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<criteria>Prepregnancy weight early first trimester weight ( BMI &gt; equal 30 kg/m2 ) Women either plan pregnancy ( try conceive try conceive come 6 month ) &lt; 14 week pregnant More two first trimester pregnancy loss History deliver infant major congenital anomaly Preexisting diabetes Autoimmune disease lupus Chronic inflammatory condition rheumatoid arthritis Uncontrolled stage two three hypertension baseline ( systolic &gt; 160 diastolic &gt; 100 mmHg ) On anticoagulant therapy History cigarette smoking within past 12 month Lactose intolerant Vegan Unwilling stop take current supplement</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Maternal Obesity</keyword>
	<keyword>Inflammation</keyword>
</DOC>